STILLA TECHNOLOGIES
Startup
STILLA TECHNOLOGIES
Description
Stilla Technologies develops a digital PCR (dPCR) solution, the Naica System workflow, designed to detect and quantify DNA mutations with high precision. It is composed by Crystal Digital PCR quantification of nucleic acids, Prism3 instrument to read crystals using 3 fluorescent channels and the Crystal Miner™ software to measure the concentrations of targeted nucleic acids.
STILLA TECHNOLOGIES
Address
Contact
support@stilla.fr
Description
Stilla Technologies develops a digital PCR (dPCR) solution, the Naica System workflow, designed to detect and quantify DNA mutations with high precision. It is composed by Crystal Digital PCR quantification of nucleic acids, Prism3 instrument to read crystals using 3 fluorescent channels and the Crystal Miner™ software to measure the concentrations of targeted nucleic acids.
Matchmaking
Connect with STILLA TECHNOLOGIES
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways